Equity Analysis

Key Financial Ratios
    Glenmark Life Sciences Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
    BSE Code
    ISIN Demat
    Book Value()
    543322
    INE03Q201024
    207.1673323
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    GLS
    31.28
    13247.64
    EPS(TTM)
    Face Value()
    Div & Yield %:
    34.56
    2
    2.08
     
   ParticularsMar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Debt-Equity Ratio0.010.010.000.000.00
Long Term Debt-Equity Ratio0.010.000.000.000.00
Current Ratio3.653.781.901.000.77
Fixed Assets2.342.633.133.022.87
Inventory3.593.864.124.073.78
Debtors2.902.923.283.002.83
Interest Cover Ratio408.281143.9321.206.3813.56
PBIDTM (%)30.0631.0629.7131.4031.48
PBITM (%)27.7229.1127.9229.6329.57
PBDTM (%)29.9931.0328.3926.7529.30
CPM (%)22.9723.5521.5120.4222.28
APATM (%)20.6221.6119.7218.6520.37
ROCE (%)27.9429.8042.2096.75185.60
RONW (%)21.0722.2829.8360.91127.84